GeneOne Life Science announced the initiation of a collaborative research program with Inovio Pharmaceuticals (Nasdaq: INO) to test and ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE